N6-methyladenosine
N6-methyladenosine - Related Videos
08:40
Dot Blot Assay for Detecting Global N6-Methyladenosine RNA Modification Levels
0 Views •
2026
Here, we present a protocol to semi-quantitatively assess global m⁶A levels using dot blot. Total RNA is extracted, denatured, spotted on a nylon membrane, probed with anti-m⁶A antibody, and visualized by chemiluminescence. Signal intensity, quantified by ImageJ grayscale analysis, reflects relative methylation abundance, providing a reproducible workflow for research.
08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
0 Views •
Cited by 7 •
2016
A modified northern blotting method for measuring N6-methyladenosine (m6A) modifications in RNA is described. The current method can detect modifications in diverse RNAs and controls under various experimental designs.
05:16
MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
0 Views •
2025
This protocol provides a detailed approach to assessing m6A modification levels of specific RNA using MeRIP-qPCR.
06:38
Plant Sample Preparation for Nucleoside/Nucleotide Content Measurement with An HPLC-MS/MS
0 Views •
Cited by 3 •
2021
A precise and reproducible method for in vivo nucleosides/nucleotides quantification in plants is described here. This method employs an HPLC-MS/MS.
FAQs
Cellular RNA regulation reflects a balance between enzymes that place m6A marks and enzymes that remove them. METTL3-METTL14 adds methyl groups, whereas FTO and ALKBH5 can reverse the modification. Changing this balance may alter how RNA is processed or used, allowing cells to adjust gene-expression programs during development, immune activity, metabolism, or disease.
Reader proteins interpret the presence of m6A and connect the modification to downstream RNA behavior. Their recognition can influence splicing, stability, transport, or translation, so the same type of chemical mark can affect gene expression through several RNA-processing routes. This provides a mechanism for translating an RNA modification into distinct cellular outcomes.
Because m6A can be added and removed, its regulatory effects are potentially adjustable rather than permanently fixed in the RNA sequence. This dynamic control helps explain how cells respond to changing biological demands and why abnormal writer, eraser, or reader activity may contribute to disease. Reversibility also makes these pathways relevant to therapeutic research.
Research connects m6A regulation with development, immunity, metabolism, and tumor progression. These areas depend on coordinated changes in gene expression, and altered RNA modification may disrupt that coordination. Examining m6A pathways therefore helps medicine investigate how molecular RNA control contributes to normal physiology and to pathological states, particularly cancer.
Disease-associated changes in RNA modification pathways may provide measurable signals for biomarker research. Investigators can examine abnormal activity involving writers, erasers, or readers and relate those patterns to conditions such as cancer or other diseases. The medical value lies in identifying molecular features that help characterize disease biology and potentially guide future clinical investigation.
A potential strategy is to target dysregulated components of the m6A pathway, including enzymes that add or remove marks or proteins that interpret them. Such interventions could aim to correct abnormal RNA control rather than address only a downstream symptom. The approach remains a research direction connected to cancer and other diseases, not a general treatment established by the overview.